Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.

about

Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.

Item

http://www.wikidata.org/entity/Q35594038

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@ast

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@en

type

Item

label

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@ast

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@en

prefLabel

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@ast

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@en

P1476

Novel chemotherapeutic and tar ...... cancer: the time has arrived.

@en

P2093

Bert H O'Neil

http://www.w3.org/2001/XMLSchema#string

Richard M Goldberg

http://www.w3.org/2001/XMLSchema#string

P2860

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Role of an anti-epidermal growth factor receptor in treating cancer.

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.

CI-1033, a pan-erbB tyrosine kinase inhibitor.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

P304

1939-1949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1517/13543784.12.12.1939

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14640938

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

chemotherapy